p.94 抽出テキスト

Recommendations for the diagnosis and treatment of PE during pregnancy are the same as in the general 2018 ESC Guidelines for the management of CVD during pregnancy741 and 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism.566 Determination of VTE risk score and the use of thromboprophylaxis protocols may be useful to prevent maternal morbidity and/or mortality due to VTE.770 LMWH have become the drug of choice for the prophylaxis and treatment of VTE in pregnant patients.741 The recommendation for thromboprophylaxis should be individualized, weighing the risks of bleeding vs. thromboembolism in pregnant patients with cancer.

1st trimester Follow-up Anthracycline chemotherapy

1st trimester Anthracycline chemotherapy Follow-up

ECG

TTE

Physical examination Baseline Week

12 Week

20

Every visit Every 4–8 W Week

34 Delivery 12 M

Cardiac monitoring protocol for pregnant women receiving

anthracycline-based chemotherapy

ECG

cTn/NP

Class 1 Class 1Ia Class 1Ib

Figure 41 Cardiac monitoring protocol for pregnant women receiving anthracycline-based chemotherapy. cTn, cardiac troponin; ECG, electrocardiogram; M, months; NP, natriuretic peptides; TTE, transoesophageal echocardiography; W, week. Downloaded from academic.oup.com/eurheartj/article/43/41/4229/6673995 by guest on 07 October 2026